Use of bisphosphonates and reduced risk of colorectal cancer.
about
Bisphosphonate use and gastrointestinal tract cancer risk: meta-analysis of observational studiesOral bisphosphonates and colon cancer: an updateExposure to bisphosphonates and risk of colorectal cancerBone Metastases: An Overview.Primary prevention of colorectal cancer: myth or reality?Exposure to bisphosphonates and risk of gastrointestinal cancers: series of nested case-control studies with QResearch and CPRD data.Repurposing of bisphosphonates for the prevention and therapy of nonsmall cell lung and breast cancerBisphosphonates inactivate human EGFRs to exert antitumor actions.Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medicationsExposure to bisphosphonates and risk of cancer: a protocol for nested case-control studies using the QResearch primary care database.A prospective study of bisphosphonate use and risk of colorectal cancerExposure to oral bisphosphonates and risk of cancer.Bisphosphonates as potential adjuvants for patients with cancers of the digestive system.Bisphosphonate use and risk of colorectal cancer: a systematic review and meta-analysis.The invisible arm of immunity in common cancer chemoprevention agents.Oral bisphosphonate use and colorectal cancer incidence in the Women's Health Initiative.Oral bisphosphonates and colorectal cancer.Zoledronic acid in the treatment of early-stage breast cancer: is there a final verdict?Potential therapeutic effects of oral bisphosphonates on the intestine.Systemic therapy for bone metastases.Beyond aspirin-cancer prevention with statins, metformin and bisphosphonates.Long-term risks of bisphosphonate therapy.The Characteristics of Bone Metastasis in Patients with Colorectal Cancer: A Long-Term Report from a Single Institution.Effectiveness of bisphosphonate use and risk of contralateral breast cancer and recurrence in women with early-stage breast cancer treated with tamoxifen.Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases study.Incidence and risk factors of bisphosphonate-related osteonecrosis of the jaw in multiple myeloma patients having undergone autologous stem cell transplantation.Exposure to bisphosphonates and risk of colorectal cancer: a population-based nested case-control study.Acute phase response after zoledronic acid is associated with long-term effects on white blood cells.Oral alendronate use and risk of cancer in postmenopausal women with osteoporosis: A nationwide study.Reduced colon cancer incidence and mortality in postmenopausal women treated with an oral bisphosphonate--Danish National Register Based Cohort Study.Oral bisphosphonate use and lung cancer incidence among postmenopausal women.Long-Term Effects of Amino-Bisphosphonates on Circulating γδ T Cells
P2860
Q24621774-788AD333-A08E-4B68-8849-FE54D9F7C3DAQ26796479-68885509-6652-4CA6-BD91-AE41D687D829Q27022446-5221F2FD-C7EC-4AA0-82B1-5DE42DE55688Q33727278-5DECCE3D-A882-4FDD-B0F6-543D19ACE7D8Q34447238-78AFFE0A-AF68-4B11-89DA-EAC57478D063Q34550590-7478988D-2DBB-4BFB-9364-36872AE81D82Q34752800-0D57F71A-AB57-47CD-BA0A-3F453DFDA7D6Q34752876-37E081E8-CF74-4B98-95F8-B0C92684BEDCQ35740351-739830B9-F1CF-457A-90CC-C97596A9E70EQ35753917-D6FAD115-3AA2-4CB0-8B3F-983915B71551Q36212417-52259C91-8573-4CB9-9912-50444009A284Q36455050-C0BB900A-5BE8-4900-B040-E14470EDDCCDQ36471673-87575C73-F990-46E3-8E10-49A472B3CC82Q37161879-0DCB89A9-C255-4DB6-AD68-673D4B1D2EA3Q37172099-C974AC13-86DE-457A-86B0-C3C87CD15CBCQ37237785-8D98A931-29EA-4695-8CE1-6510E24027FBQ37692229-9D0C75FE-871C-462C-98C3-8CDF59B79C97Q37960410-408195FF-FA4D-42B5-98C9-70A1533056E5Q37987554-187FBACE-05B4-4BEC-88F7-69F4A8104673Q38001276-88797DE6-509D-4EB1-81A6-649676014F35Q38147841-5A1BADC5-8D13-4548-A0D8-68C3DB065994Q38244171-08720889-0003-42CD-A455-F65B785C18D7Q38626370-78BBDFBE-8AC1-444E-A76A-3A2BA33FA625Q39899122-D3551984-D807-4EA2-A7A6-57B2940634ADQ43592607-88583E46-4488-4A72-92B0-F3B05824C98DQ44042571-9ADA2B72-B7FE-47C5-ADD1-CC80B3E9D6A8Q45075711-63B67720-2A06-4426-9C5A-A5465EBD14E0Q45731159-21BF9CEA-13EC-45B1-9BD8-040C193C5CBDQ48692383-08296F36-5593-4D65-B65D-900313BCA50BQ50555866-6E2BF3EF-43A7-4A26-9CB4-A3C05219B0ECQ55237144-1E23F014-979D-4FC2-A68E-F204278748D7Q58903536-5306B367-D8D2-479E-8064-B78D85FA1108
P2860
Use of bisphosphonates and reduced risk of colorectal cancer.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Use of bisphosphonates and reduced risk of colorectal cancer.
@ast
Use of bisphosphonates and reduced risk of colorectal cancer.
@en
Use of bisphosphonates and reduced risk of colorectal cancer.
@nl
type
label
Use of bisphosphonates and reduced risk of colorectal cancer.
@ast
Use of bisphosphonates and reduced risk of colorectal cancer.
@en
Use of bisphosphonates and reduced risk of colorectal cancer.
@nl
prefLabel
Use of bisphosphonates and reduced risk of colorectal cancer.
@ast
Use of bisphosphonates and reduced risk of colorectal cancer.
@en
Use of bisphosphonates and reduced risk of colorectal cancer.
@nl
P2093
P2860
P356
P1476
Use of bisphosphonates and reduced risk of colorectal cancer.
@en
P2093
Hedy S Rennert
Mila Pinchev
Stephen B Gruber
P2860
P304
P356
10.1200/JCO.2010.33.7485
P407
P50
P577
2011-02-14T00:00:00Z